Early detection: Proteomic applications for the early detection of cancer

The ability of physicians to effectively treat and cure cancer is directly dependent on their ability to detect cancers at their earliest stages. Proteomic analyses of early-stage cancers have provided new insights into the changes that occur in the early phases of tumorigenesis and represent a new resource of candidate biomarkers for early-stage disease. Studies that profile proteomic patterns in body fluids also present new opportunities for the development of novel, highly sensitive diagnostic tools for the early detection of cancer.

[1]  M. Uslenghi,et al.  The World Space Observatory (WSO-UV) - Current status , 2008, 0801.2080.

[2]  Hans A. Linde,et al.  The United States Experience , 1972 .

[3]  Julius T. Tou,et al.  Pattern Recognition Principles , 1974 .

[4]  C. L. Chang,et al.  The relationship between the mass spectra of drugs and their biological activity--an application of artificial intelligence to chemistry. , 1975, Computers in biology and medicine.

[5]  T. Kohonen.  Self-organized formation of topographically correct feature maps , 1982 .

[6]  S. Teutsch,et al.  Measurement of prostate-specific antigen as a screening test for prostate cancer , 1991 .

[7]  M. Friedlander,et al.  Prognostic factors in ovarian cancer. , 1992, Seminars in oncology.

[8]  Friedland Ml,et al.  Prognostic factors in ovarian cancer. , 1991 .

[9]  C. Perez,et al.  Principles and Practice of Gynecologic Oncology , 1992 .

[10]  John H. Holland,et al.  Adaptation in Natural and Artificial Systems: An Introductory Analysis with Applications to Biology, Control, and Artificial Intelligence , 1992 .

[11]  H. Jörnvall,et al.  Analysis of polypeptide expression in benign and malignant human breast lesions , 1997, Electrophoresis.

[12]  D. Ornstein,et al.  Prostate-specific antigen as a screening test for prostate cancer. The United States experience. , 1997, The Urologic clinics of North America.

[13]  M. Ünlü,et al.  Difference gel electrophoresis. A single gel method for detecting changes in protein extracts , 1997, Electrophoresis.

[14]  Barbara Magi,et al.  Protein expression profiles in human breast ductal carcinoma and histologically normal tissue , 1997, Electrophoresis.

[15]  Teuvo Kohonen,et al.  The self-organizing map , 1990, Neurocomputing.

[16]  P. Lapuerta,et al.  Neural Network Assessment of Perioperative Cardiac Risk in Vascular Surgery Patients , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[17]  Steven J Skates,et al.  Screening for ovarian cancer: a pilot randomised controlled trial , 1999, The Lancet.

[18]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[19]  H. Lehrach,et al.  Protein microarrays for gene expression and antibody screening. , 1999, Analytical biochemistry.

[20]  S. Gygi,et al.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.

[21]  L. G. Mendoza,et al.  High-throughput microarray-based enzyme-linked immunosorbent assay (ELISA). , 1999, BioTechniques.

[22]  R. Kuick,et al.  Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas , 1999, British Journal of Cancer.

[23]  L. Edenbrandt,et al.  Myocardial SPET: artificial neural networks describe extent and severity of perfusion defects. , 1999, Clinical physiology.

[24]  D. Pappin,et al.  The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis — Preliminary findings , 1999, Electrophoresis.

[25]  T. Ørntoft,et al.  Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions. , 1999, Cancer research.

[26]  C. Paweletz,et al.  Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  Pierre Thibault,et al.  Rapid and sensitive separation of trace level protein digests using microfabricated devices coupled to a quadrupole ‐ time‐of‐flight mass spectrometer , 2000, Electrophoresis.

[28]  A. Görg,et al.  The current state of two‐dimensional electrophoresis with immobilized pH gradients , 2000, Electrophoresis.

[29]  E. Petricoin,et al.  Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip , 2000 .

[30]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[31]  S M Hanash,et al.  Biomedical applications of two‐dimensional electrophoresis using immobilized pH gradients: Current status , 2000, Electrophoresis.

[32]  P R Taylor,et al.  Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. , 2000, Cancer research.

[33]  Emanuel Petricoin,et al.  Molecular profiling of human cancer , 2000, Nature Reviews Genetics.

[34]  I. Tomlinson,et al.  Antibody arrays for high-throughput screening of antibody–antigen interactions , 2000, Nature Biotechnology.

[35]  J. Celis,et al.  Bladder squamous cell carcinoma biomarkers derived from proteomics , 2000, Electrophoresis.

[36]  M E Belov,et al.  High-throughput proteomics using high-efficiency multiple-capillary liquid chromatography with on-line high-performance ESI FTICR mass spectrometry. , 2001, Analytical chemistry.

[37]  G. Wright,et al.  Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. , 2001, The American journal of pathology.

[38]  M. Stoeckli,et al.  Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues , 2001, Nature Medicine.

[39]  B. Chait,et al.  Automatic identification of proteins with a MALDI-quadrupole ion trap mass spectrometer. , 2001, Analytical chemistry.

[40]  L. Liotta,et al.  Proteomic Patterns of Nipple Aspirate Fluids Obtained by SELDI-TOF: Potential for New Biomarkers to Aid in the Diagnosis of Breast Cancer , 2002, Disease markers.

[41]  David E. Misek,et al.  Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[42]  Maxey C M Chung,et al.  Hepatocellular carcinoma: From bedside to proteomics , 2001, Proteomics.

[43]  J. Yates,et al.  Large-scale analysis of the yeast proteome by multidimensional protein identification technology , 2001, Nature Biotechnology.

[44]  S. Hanash,et al.  Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. , 2001, Cancer research.

[45]  L. Liotta,et al.  Proteomic profiling of the cancer microenvironment by antibody arrays , 2001, Proteomics.

[46]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[47]  A. Vlahou,et al.  Proteomic approaches to biomarker discovery in prostate and bladder cancers , 2001, Proteomics.

[48]  B. Kramer,et al.  Trends in biomarker research for cancer detection. , 2001, The Lancet. Oncology.

[49]  P. Schellhammer,et al.  Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. , 2001, Cancer research.

[50]  S M Hanash,et al.  Protein based microarrays: A tool for probing the proteome of cancer cells and tissues , 2001, Proteomics.

[51]  D. Cahill,et al.  Protein and antibody arrays and their medical applications. , 2001, Journal of immunological methods.

[52]  E. Petricoin,et al.  Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.

[53]  O John Semmes,et al.  Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[54]  N. Kiviat,et al.  Novel Approaches to Identification of Biomarkers for Detection of Early Stage Cancer , 2002, Disease markers.

[55]  E. Petricoin,et al.  Proteomics of human breast ductal carcinoma in situ. , 2002, Cancer research.

[56]  Nan Hu,et al.  2D Differential In-gel Electrophoresis for the Identification of Esophageal Scans Cell Cancer-specific Protein Markers* , 2002, Molecular & Cellular Proteomics.

[57]  G. Li,et al.  An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers , 2002, Bioinform..

[58]  A. Link.  Multidimensional peptide separations in proteomics. , 2002, Trends in biotechnology.

[59]  E. Petricoin,et al.  Serum proteomic patterns for detection of prostate cancer. , 2002, Journal of the National Cancer Institute.

[60]  Sharon L R Kardia,et al.  Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[61]  C. Der,et al.  Loss of Transgelin in Breast and Colon Tumors and in RIE-1 Cells by Ras Deregulation of Gene Expression through Raf-independent Pathways* , 2002, The Journal of Biological Chemistry.

[62]  P. Schellhammer,et al.  Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. , 2002, Cancer research.

[63]  D. Chan,et al.  Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. , 2002, Clinical chemistry.

[64]  E. Petricoin,et al.  Clinical proteomics: translating benchside promise into bedside reality , 2002, Nature Reviews Drug Discovery.

[65]  Richard M Caprioli,et al.  Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections. , 2002, Current opinion in chemical biology.

[66]  P. Selby,et al.  Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitations. , 2002, The American journal of pathology.

[67]  E. Kohn,et al.  Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer , 2002, Proteomics.

[68]  D. L. Diamond,et al.  Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer. , 2002, Biochemistry.

[69]  Richard M Caprioli,et al.  Direct profiling and imaging of peptides and proteins from mammalian cells and tissue sections by mass spectrometry , 2002, Electrophoresis.

[70]  Morten Østergaard,et al.  Proteomic Strategies to Reveal Tumor Heterogeneity among Urothelial Papillomas * , 2002, Molecular & Cellular Proteomics.

[71]  R. Berkowitz,et al.  Osteopontin as a potential diagnostic biomarker for ovarian cancer. , 2002, JAMA.

[72]  Laura Beretta,et al.  A Distinct Repertoire of Autoantibodies in Hepatocellular Carcinoma Identified by Proteomic Analysis* , 2002, Molecular & Cellular Proteomics.

[73]  J. Lindon,et al.  Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.

[74]  E. Sauter,et al.  Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer , 2002, British Journal of Cancer.

[75]  John R Yates,et al.  Analysis of quantitative proteomic data generated via multidimensional protein identification technology. , 2002, Analytical chemistry.

[76]  P. Schellhammer,et al.  Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. , 2002, Clinical chemistry.

[77]  Barry Schweitzer,et al.  Measuring proteins on microarrays. , 2002, Current opinion in biotechnology.

[78]  P. Brown,et al.  Autoantigen microarrays for multiplex characterization of autoantibody responses , 2002, Nature Medicine.

[79]  David Sidransky,et al.  Emerging molecular markers of cancer , 2002, Nature Reviews Cancer.

[80]  K. Lillemoe,et al.  Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. , 2002, Cancer research.

[81]  K. Meehan,et al.  Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer , 2002, The Prostate.

[82]  E. Petricoin,et al.  Proteomic analysis of human prostate cancer † , 2002, Molecular carcinogenesis.

[83]  A. Whittemore,et al.  Survival among U.S. women with invasive epithelial ovarian cancer. , 2002, Gynecologic oncology.

[84]  Teuvo Kohonen,et al.  Self-organized formation of topologically correct feature maps , 2004, Biological Cybernetics.